MX14210A - Procedimiento para preparar inhibidores no-peptidicos de renina - Google Patents

Procedimiento para preparar inhibidores no-peptidicos de renina

Info

Publication number
MX14210A
MX14210A MX1421088A MX1421088A MX14210A MX 14210 A MX14210 A MX 14210A MX 1421088 A MX1421088 A MX 1421088A MX 1421088 A MX1421088 A MX 1421088A MX 14210 A MX14210 A MX 14210A
Authority
MX
Mexico
Prior art keywords
alkyl
renina
procedure
preparing non
peptidic inhibitors
Prior art date
Application number
MX1421088A
Other languages
English (en)
Inventor
Robert Louis Rosati
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX14210A publication Critical patent/MX14210A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
MX1421088A 1987-12-15 1988-12-15 Procedimiento para preparar inhibidores no-peptidicos de renina MX14210A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13237387A 1987-12-15 1987-12-15

Publications (1)

Publication Number Publication Date
MX14210A true MX14210A (es) 1993-05-01

Family

ID=22453720

Family Applications (1)

Application Number Title Priority Date Filing Date
MX1421088A MX14210A (es) 1987-12-15 1988-12-15 Procedimiento para preparar inhibidores no-peptidicos de renina

Country Status (27)

Country Link
EP (1) EP0321192B1 (es)
JP (1) JPH0692366B2 (es)
KR (1) KR900009022B1 (es)
CN (1) CN1025676C (es)
AT (1) ATE96433T1 (es)
AU (1) AU593181B2 (es)
CA (1) CA1314545C (es)
CS (1) CS274671B2 (es)
DD (1) DD283381A5 (es)
DE (1) DE3885252T2 (es)
DK (1) DK694888A (es)
EG (1) EG18927A (es)
ES (1) ES2059540T3 (es)
FI (1) FI88295C (es)
HU (1) HU201564B (es)
IE (1) IE61548B1 (es)
IL (1) IL88619A0 (es)
MX (1) MX14210A (es)
MY (1) MY104354A (es)
NO (1) NO172935C (es)
NZ (1) NZ227322A (es)
PH (1) PH26974A (es)
PL (1) PL152507B1 (es)
PT (1) PT89210B (es)
SU (1) SU1651786A3 (es)
YU (1) YU46686B (es)
ZA (1) ZA889307B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2638747B1 (fr) * 1988-11-08 1993-12-24 Synthelabo Derives de phenyloxypropanolamines, leur preparation et leur application en therapeutique
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
DE4035846A1 (de) * 1990-11-10 1991-06-06 Kuntze Angelgeraete Dam Angelrolle mit spule zur aufnahme der angelschnur
EP0966443B1 (en) * 1997-02-26 2009-01-28 Pfizer Inc. Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
EP1498417A1 (en) * 2000-02-04 2005-01-19 Pfizer Products Inc. Heterocyclic amide derivatives
CZ20022542A3 (cs) 2000-02-04 2003-08-13 Pfizer Products Inc. Heterocyklické amidové deriváty
US20040097554A1 (en) * 2002-10-30 2004-05-20 Pfizer Inc Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents
US7405210B2 (en) 2003-05-21 2008-07-29 Osi Pharmaceuticals, Inc. Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
BRPI0410445B1 (pt) * 2003-05-21 2017-11-28 Prosidion Limited Pyrrolopyridine-2-carboxylic acid amide inhibitor compound of glycogen phosphorylase, pharmaceutical composition comprising the same, process for its production and intermediate compounds
CN108218865B (zh) * 2018-03-31 2020-06-26 济南市儿童医院 一种酰胺类衍生物及其在心脑血管方面的应用
CN108164528B (zh) * 2018-03-31 2019-03-22 杭州巴洛特生物科技有限公司 一种酰胺类衍生物及其在高血压、高血脂和动脉粥样硬化中的应用
CN108456207B (zh) * 2018-03-31 2020-11-20 浙江药苑生物科技有限公司 一种酰胺类衍生物及其在心脑血管方面的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0181110A3 (en) * 1984-10-22 1988-05-11 Kissei Pharmaceutical Co. Ltd. Histidine derivatives as renin inhibitors
US4727060A (en) * 1984-11-13 1988-02-23 Ciba-Geigy Corporation Novel 5-amino-4-hydroxyvaleryl derivatives

Also Published As

Publication number Publication date
CN1025676C (zh) 1994-08-17
SU1651786A3 (ru) 1991-05-23
NO885549D0 (no) 1988-12-14
KR900009022B1 (ko) 1990-12-17
ATE96433T1 (de) 1993-11-15
CN1034366A (zh) 1989-08-02
DK694888D0 (da) 1988-12-14
NO885549L (no) 1989-06-16
NZ227322A (en) 1990-06-26
NO172935C (no) 1993-09-29
EP0321192A2 (en) 1989-06-21
PT89210A (pt) 1989-12-29
ZA889307B (en) 1990-08-29
ES2059540T3 (es) 1994-11-16
DE3885252T2 (de) 1994-02-17
MY104354A (en) 1994-03-31
PL276363A1 (en) 1989-08-07
CA1314545C (en) 1993-03-16
JPH01250345A (ja) 1989-10-05
PH26974A (en) 1992-12-28
CS820388A2 (en) 1990-10-12
AU2688188A (en) 1989-06-15
IE883731L (en) 1989-06-15
AU593181B2 (en) 1990-02-01
DK694888A (da) 1989-08-11
JPH0692366B2 (ja) 1994-11-16
NO172935B (no) 1993-06-21
FI88295C (fi) 1993-04-26
PT89210B (pt) 1993-09-30
HU201564B (en) 1990-11-28
HUT48277A (en) 1989-05-29
CS274671B2 (en) 1991-09-15
FI885783A (fi) 1989-06-16
DE3885252D1 (de) 1993-12-02
EG18927A (en) 1996-03-31
YU225788A (en) 1990-04-30
FI88295B (fi) 1993-01-15
YU46686B (sh) 1994-04-05
IL88619A0 (en) 1989-07-31
IE61548B1 (en) 1994-11-16
EP0321192A3 (en) 1991-01-30
PL152507B1 (en) 1991-01-31
FI885783A0 (fi) 1988-12-14
DD283381A5 (de) 1990-10-10
EP0321192B1 (en) 1993-10-27
KR890009867A (ko) 1989-08-04

Similar Documents

Publication Publication Date Title
MX14210A (es) Procedimiento para preparar inhibidores no-peptidicos de renina
PL352413A1 (en) Quinoline derivatives as inhibitors of mek enzymes
ES2191484T3 (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa.
BG105855A (en) 2-aminopyridines containing fused ring substituents
DK165247C (da) 2,3,4,5-substituerede 1,6-naphthyridinderivater, deres fremstilling samt anvendelse af disse til fremstilling af laegemidler til bekaempelse af cardiale, cerebrale og perifere karlidelser, myocardial iskaemi, cerebral infarkt, lungethrombose, stenoser, arterioscleroser og hjerte-kredsloebslidelser og laegemiddel indeholdende disse derivater
PT1021404E (pt) Derivados de azetidinona para o tratamento de infeccoes pelo hcmv
EP0726269A4 (en) QUINOLINE CARBONIC ACID DERIVATIVE AND ITS SALTS
ES2053742T3 (es) Derivados de 2'-deoxi-5-fluorouridina.
FR2800373B1 (fr) Procede de preparation d'oxazoles trisubstitues
CA1264500C (en) N SUBSTITUTION DERIVATIVES OF AMIDO-AMINO-ACIDS